RA PHARMACEUTICALS INC's ticker is RARX and the CUSIP is 74933V108. A total of 65 filers reported holding RA PHARMACEUTICALS INC in Q2 2017. The put-call ratio across all filers is - and the average weighting 0.3%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q1 2020 | $903,000 | -64.1% | 18,816 | -64.8% | 0.02% | +53.3% |
| Q4 2019 | $2,512,000 | +170.4% | 53,530 | +73.3% | 0.02% | +66.7% |
| Q2 2019 | $929,000 | +34.1% | 30,880 | -0.2% | 0.01% | +28.6% |
| Q1 2019 | $693,000 | +1.3% | 30,943 | -17.7% | 0.01% | -12.5% |
| Q4 2018 | $684,000 | -28.9% | 37,602 | -29.3% | 0.01% | -33.3% |
| Q3 2018 | $962,000 | +524.7% | 53,199 | +242.8% | 0.01% | +500.0% |
| Q2 2018 | $154,000 | -7.8% | 15,521 | -20.8% | 0.00% | -33.3% |
| Q4 2017 | $167,000 | -15.2% | 19,592 | +86.6% | 0.00% | -25.0% |
| Q2 2017 | $197,000 | – | 10,500 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| RA Capital Management | 3,851,808 | $20,453,000 | 1.57% |
| NEA Management Company, LLC | 5,493,636 | $29,171,000 | 1.30% |
| Foresite Capital Management IV, LLC | 450,000 | $2,390,000 | 0.99% |
| Novo Holdings A/S | 1,465,838 | $7,784,000 | 0.98% |
| Consonance Capital Management LP | 1,454,761 | $7,725,000 | 0.71% |
| VHCP Management II, LLC | 544,612 | $2,892,000 | 0.70% |
| ACUTA CAPITAL PARTNERS, LLC | 270,000 | $1,434,000 | 0.23% |
| Athanor Capital, LP | 67,150 | $357,000 | 0.16% |
| Rock Springs Capital Management LP | 600,000 | $3,186,000 | 0.14% |
| Eventide Asset Management | 388,000 | $2,060,000 | 0.10% |